The two tops are slightly different but probably close enough to call a double if you were so inclined. But for the double top to play out, it'll need to fall back through the low at 330 to be proven. There's no way this will fall that far unless POG craps itself or there's an issue at one of the mines.
With the gap 453 closed, there is one more at 380 but again, it's really unlikely to happen without a major catalyst. The business is just too healthy.
If anything the 200EMA at 435 might act as a magnet so we may have more weakness to come but if this weakness persists, the risk of TO becomes very real. The Tier 1 goldies are on the prowl and SBM looks very attractive at these levels.
The shortsightedness of traders and other players that view the GMX CAPEX and AISC as pain-points are just that: shortsighted. The key metrics for post-GMX are really impressive so it wont be long before major money begins to buy the >2 year view and cashflows.
Anyway, I've added at the gap (453) and will add again at the 200EMA. This madness can't continue forever. Can it...?
- Forums
- ASX - By Stock
- SBM
- Bottom of Channel Alert
Bottom of Channel Alert, page-5
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBM (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $249.5M |
Open | High | Low | Value | Volume |
30.5¢ | 31.0¢ | 29.5¢ | $7.624M | 25.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 466340 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 241764 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 446340 | 0.300 |
30 | 879243 | 0.295 |
24 | 972189 | 0.290 |
17 | 1328031 | 0.285 |
17 | 207855 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 241764 | 7 |
0.310 | 243702 | 9 |
0.315 | 477490 | 10 |
0.320 | 612634 | 9 |
0.325 | 318596 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
SBM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online